SCHEMBL5566765

SCHEMBL5566765

CC(C)(N)CNC(=O)c1ccc(C2(CN3CCCC3)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 4/20 0.50
▸ F2 P00734 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.41
▸ POLB P06746 2/20 0.41
▸ P2RY1 P47900 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ HSD11B1 P28845 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5570726 0.81 F10 (0.50) F10F2NPSR1POLBALDH1A1
SCHEMBL5570724 0.81 F10 (0.50) F10F2NPSR1POLBALDH1A1
SCHEMBL5569550 0.81 F10 (0.48) F10F2NPSR1POLBP2RY1
SCHEMBL5569549 0.81 F10 (0.48) F10F2NPSR1POLBP2RY1
SCHEMBL5567238 0.81 F10 (0.48) F10F2NPSR1POLBALDH1A1
SCHEMBL5670078 0.81 F10 (0.65) F10F2P2RY1ALDH1A1CYP2C9
SCHEMBL5566762 0.80 F10 (0.47) F10F2NPSR1POLBALDH1A1
SCHEMBL5569370 0.80 F10 (0.48) F10F2NPSR1POLBALDH1A1
SCHEMBL5567235 0.79 F10 (0.48) F10F2NPSR1POLBP2RY1
SCHEMBL5669697 0.78 ALDH1A1 (0.62) F10F2NPSR1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
Send feedback